A randomized clinical trial comparing fixed vs pro-re-nata dosing of Ozurdex in refractory diabetic macular oedema (OZDRY study) – (Eye 29, 1603 (December 2015))

10 December 2015

This news item is available to RCOphth members only, please log in below to access.